S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Bear Market Expert Reveals His #1 Stock for November 2023  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
"The Bull Market Is Officially OVER"  (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
LON:AVO

Advanced Oncotherapy - AVO Share Forecast, Price & News

GBX 16.75
-0.25 (-1.49%)
(As of 12/8/2022 04:05 AM ET)
Add
Compare
Today's Range
16.51
16.75
50-Day Range
16.50
24.50
52-Week Range
16.50
40
Volume
1,890 shs
Average Volume
286,135 shs
Market Capitalization
£89.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AVO stock logo

About Advanced Oncotherapy (LON:AVO) Stock

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

Advanced Oncotherapy raises £2mln at a premium
Advanced Oncotherapy plc (AVO.L)
Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
Advanced Oncotherapy : Result of AGM
Advanced Oncotherapy says 2021 to be important year
Advanced Oncotherapy : Total Voting Rights
See More Headlines
Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Company Calendar

Last Earnings
6/29/2020
Today
12/08/2022

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
139
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.49 per share
Book Value
GBX 13.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£89.01 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Michael Jeffrey Sinclair (Age 79)
    Exec. Chairman
    Comp: $434.42k
  • Mr. Nicolas Serandour
    CEO & Exec. Director
  • Prof. Stephen Myers OBE (Age 75)
    Exec. Director
    Comp: $397.72k
  • Mr. Ed Lee
    COO & Pres of Europe
  • Mr. Graham Pughe
    Sr. Vice-Pres of Accounting
  • Ms. Berengere Pons-Chabord
    Sr. Vice-Pres of Corp. Fin.
  • Dr. Manuel Gallas
    Director of Technical & Engineering
  • Mr. David Navas
    VP of Investor and PR
  • Ms. Bridget Biggar
    Director of HR
  • Ms. Donatella Ungaro
    Managing Director of ADAM













AVO Stock - Frequently Asked Questions

How have AVO shares performed in 2022?

Advanced Oncotherapy's stock was trading at GBX 38 on January 1st, 2022. Since then, AVO shares have decreased by 55.3% and is now trading at GBX 17.
View the best growth stocks for 2022 here
.

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).

What is Advanced Oncotherapy's stock symbol?

Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Advanced Oncotherapy's stock price today?

One share of AVO stock can currently be purchased for approximately GBX 17.

How much money does Advanced Oncotherapy make?

Advanced Oncotherapy (LON:AVO) has a market capitalization of £90.35 million.

How many employees does Advanced Oncotherapy have?

The company employs 139 workers across the globe.

How can I contact Advanced Oncotherapy?

Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The official website for the company is www.advancedoncotherapy.com. The company can be reached via phone at +44-20-36178728.

This page (LON:AVO) was last updated on 12/8/2022 by MarketBeat.com Staff